Background: The SYNTAX trial showed that coronary artery bypass grafting (CABG) remains the standard of treatment for left main and three-vessel coronary artery disease when compared with percutaneous coronary intervention (PCI), with lower rates of major cardiac and cerebrovascular events (MACCE [12.4% vs 17.8%]) and need for revascularisation at 12 months (5.9% vs 13.5%). Surgery did, however, have a higher rate of stroke in the post-operative period (2.2% vs 0.6%).
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2011 Published by Elsevier Inc.